Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis

Condition:   Asthma
Interventions:   Drug: Placebo Inhalation Powder;   Drug: Fluticasone Furoate/GW642444 Inhalation Powder;   Drug: Fluticasone Furoate/GW642444 Inhalation Powder;   Drug: Placebo Oral Capsule;   Drug: Prednisolone Oral Capsule
Sponsor:   GlaxoSmithKline
Active, not recruiting – verified October 2010

View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.